BRIEF-Myriad Genetics Announces Select Preliminary Fourth Quarter And Full Year 2025 Financial Results And Introduces Full Year 2026 Financial Guidance
Reuters
Jan 12
BRIEF-Myriad Genetics Announces Select Preliminary Fourth Quarter And Full Year 2025 Financial Results And Introduces Full Year 2026 Financial Guidance
Jan 12 (Reuters) - Myriad Genetics Inc MYGN.O:
MYRIAD GENETICS ANNOUNCES SELECT PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND INTRODUCES FULL YEAR 2026 FINANCIAL GUIDANCE
MYRIAD GENETICS INC - Q4 2025 REVENUES EXPECTED BETWEEN $207 MILLION AND $209 MILLION
MYRIAD GENETICS INC - FULL YEAR 2025 REVENUES EXPECTED BETWEEN $822 MILLION AND $824 MILLION
MYRIAD GENETICS INC - 2026 REVENUE GUIDANCE BETWEEN $860 MILLION AND $880 MILLION
Source text: ID:nGNXbfgbtv
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.